101 / 113
101
[207] D. A. Walker, J. Liu, M. Kieran, N. Jabado, S. Picton, R. Packer, C. St Rose, and CPN Paris 2011
Conference Consensus Group, “A multi-disciplinary consensus statement concerning surgical approaches
to low-grade, high-grade astrocytomas and diffuse intrinsic pontine gliomas in childhood (CPN Paris
2011) using the Delphi method,”
Neuro-Oncol.
, vol. 15, no. 4, pp. 462–468, Apr. 2013.
[208] A. Ferrari, G. Bisogno, A. Macaluso, M. Casanova, P. D’Angelo, P. Pierani, I. Zanetti, R. Alaggio, G.
Cecchetto, and M. Carli, “Soft-tissue sarcomas in children and adolescents with neurofibromatosis type
1,”
Cancer
, vol. 109, no. 7, pp. 1406–1412, Apr. 2007.
[209] E. Cecen, D. Ince, K. M. Uysal, E. Ozer, R. Cetingoz, A. A. Ozguven, H. Cakmakci, F. Sarialioglu, and N.
Olgun, “Soft tissue sarcomas and central nervous system tumors in children with neurofibromatosis type
1,”
Childs Nerv. Syst. ChNS Off. J. Int. Soc. Pediatr. Neurosurg.
, vol. 27, no. 11, pp. 1885–1893, Nov. 2011.
[210] G. Laureys, “[The neuroblastoma, ‘enfant terrible’ among pediatric tumors],”
Verh. - K. Acad. Voor
Geneeskd. Van Belg.
, vol. 65, no. 1, pp. 5–23; discussion 23–28, 2003.
[211] G. M. Haase, C. Perez, and J. B. Atkinson, “Current aspects of biology, risk assessment, and treatment
of neuroblastoma,”
Semin. Surg. Oncol.
, vol. 16, no. 2, pp. 91–104, Mar. 1999.
[212] C. Jimenez, E. Rohren, M. A. Habra, T. Rich, P. Jimenez, M. Ayala-Ramirez, and E. Baudin, “Current
and future treatments for malignant pheochromocytoma and sympathetic paraganglioma,”
Curr. Oncol.
Rep.
, vol. 15, no. 4, pp. 356–371, Aug. 2013.
[213] G. Opocher, P. Conton, F. Schiavi, B. Macino, and F. Mantero, “Pheochromocytoma in von Hippel-
Lindau disease and neurofibromatosis type 1,”
Fam. Cancer
, vol. 4, no. 1, pp. 13–16, 2005.
[214] M. C. Shinall and C. C. Solórzano, “Pheochromocytoma in Neurofibromatosis Type 1: When Should it
be Suspected?,”
Endocr. Pract. Off. J. Am. Coll. Endocrinol. Am. Assoc. Clin. Endocrinol.
, pp. 1–16, Feb.
2014.
[215] J. W. M. Lenders, Q.-Y. Duh, G. Eisenhofer, A.-P. Gimenez-Roqueplo, S. K. G. Grebe, M. H. Murad, M.
Naruse, K. Pacak, W. F. Young, and Endocrine Society, “Pheochromocytoma and paraganglioma: an
endocrine society clinical practice guideline,”
J. Clin. Endocrinol. Metab.
, vol. 99, no. 6, pp. 1915–1942,
Jun. 2014.
[216] A. Agaimy, N. Vassos, and R. S. Croner, “Gastrointestinal manifestations of neurofibromatosis type 1
(Recklinghausen’s disease): clinicopathological spectrum with pathogenetic considerations,”
Int. J. Clin.
Exp. Pathol.
, vol. 5, no. 9, pp. 852–862, 2012.
[217] D. Relles, J. Baek, A. Witkiewicz, and C. J. Yeo, “Periampullary and duodenal neoplasms in
neurofibromatosis type 1: two cases and an updated 20-year review of the literature yielding 76 cases,”
J. Gastrointest. Surg. Off. J. Soc. Surg. Aliment. Tract
, vol. 14, no. 6, pp. 1052–1061, Jun. 2010.
[218] Landelijke Werkgroep and -, “Richtlijn neuroendocriene tumoren (NET) van de tractus digestivus en
pancreas.” IKNL, 2013.
[219] M. Miettinen, J. F. Fetsch, L. H. Sobin, and J. Lasota, “Gastrointestinal stromal tumors in patients with
neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases,”
Am. J. Surg. Pathol.
,
vol. 30, no. 1, pp. 90–96, Jan. 2006.
[220] H. Joensuu, P. Hohenberger, and C. L. Corless, “Gastrointestinal stromal tumour,”
Lancet
, vol. 382,
no. 9896, pp. 973–983, Sep. 2013.
[221] J. Grill, D. Couanet, C. Cappelli, J. L. Habrand, D. Rodriguez, C. Sainte-Rose, and C. Kalifa, “Radiation-
induced cerebral vasculopathy in children with neurofibromatosis and optic pathway glioma,”
Ann.
Neurol.
, vol. 45, no. 3, pp. 393–396, Mar. 1999.
[222] T. E. Merchant, L. E. Kun, S. Wu, X. Xiong, R. A. Sanford, and F. A. Boop, “Phase II trial of conformal
radiation therapy for pediatric low-grade glioma,”
J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol.
, vol. 27, no.
22, pp. 3598–3604, Aug. 2009.
[223] S. Sharif, R. Ferner, J. M. Birch, J. E. Gillespie, H. R. Gattamaneni, M. E. Baser, and D. G. R. Evans,
“Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after
radiotherapy,”
J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol.
, vol. 24, no. 16, pp. 2570–2575, Jun. 2006.